Instalab
logoInstalab

REMS T-Score (Spine)

Assess lower-back bone density without radiation, using an emerging ultrasound method.

Should you take a REMS T-Score (Spine) test?

This test is most useful if any of these apply to you.

Going Through or Past Menopause
If you have fracture risk factors, this scan can add an ultrasound estimate of spine density to your bone-health assessment.
Concerned About Your Family's Fracture History
A family history of hip fracture makes a bone-health assessment more useful; REMS is one possible part of it.
Taking Steroids Long Term
Long-term steroid treatment can weaken bone. REMS may complement the DXA and fracture assessment used to guide protection.
Living With Arthritis in Your Back
Arthritis can inflate spine DXA readings. REMS may add information, though a lower ultrasound score isn't automatically more accurate.

About REMS T-Score (Spine)

Bone loss often causes no symptoms before a fracture. Measuring bone density can reveal that loss earlier, but the method matters. REMS estimates lower-spine bone density using ultrasound, without radiation.

REMS has human validation studies and evidence linking its results to later fractures. It remains an emerging clinical method. DXA is the established reference for osteoporosis diagnosis and most treatment-monitoring decisions, and agreement between the two methods varies substantially across populations.

What the Score Measures

REMS stands for radiofrequency echographic multi spectrometry. A probe on your abdomen sends sound waves toward the lumbar vertebrae. Software analyzes the returning signals and compares them with reference patterns, using information including age, sex, body size, and the bone being examined to estimate bone mineral density.

The T-score expresses how far that density estimate is from a young-adult reference average. Lower scores indicate lower estimated density. The score has no physical unit, and each step represents one standard deviation in the reference population. Your chance of fracture also depends on age, previous fractures, falls, medications, and conditions that affect bone strength.

DXA stands for dual-energy X-ray absorptiometry. It estimates bone mineral density from the absorption of low-dose X-rays. REMS derives its estimate from ultrasound signals calibrated against reference data. Their T-scores describe a similar concept, but individual results and changes over time aren't interchangeable.

How Closely It Agrees With DXA

Large European studies reported strong agreement after scan-quality checks. Studies in older adults and some chronic illnesses have found substantially poorer agreement. These comparisons use DXA as the reference, so they measure agreement with DXA rather than directly establishing which method best represents bone strength.

Who Was StudiedWhat Was ComparedWhat They Found
Women in a European multicenter study; several thousand paired spine examinations remained after quality checksREMS versus DXA classification of spine osteoporosisREMS identified about 90% of DXA-defined osteoporosis cases and agreed with the absence of DXA-defined osteoporosis in about 95% of cases
Geriatric outpatients with a median age of 75REMS versus DXA classification of spine osteoporosisREMS missed a substantially larger share of DXA-defined osteoporosis cases, and agreement on the absence of osteoporosis was also clearly lower than in the European study

The difference between these studies matters more than any single accuracy figure. Age 75 isn't a validated boundary below which the methods become interchangeable. Scan quality, the population studied, and changes in the spine all affect the comparison.

Fracture Risk

A fragility fracture occurs after an injury that healthy bone would usually withstand, such as a fall from standing height. Vertebral fractures can also occur without a memorable injury and may cause height loss or a rounded upper back.

In an Italian study, 1,370 women completed follow-up lasting an average of 3.7 years. Women classified as having osteoporosis by the REMS spine score had clearly higher odds of a subsequent fragility fracture than women outside that category, and REMS predicted fractures about as well as DXA in the same cohort. This supports fracture prediction by REMS, but it doesn't establish that treatment decisions based on REMS prevent more fractures than decisions based on DXA.

Some REMS reports also include a Fragility Score. This is a separate ultrasound-derived indicator based on signal patterns associated with skeletal fragility. It isn't a direct image of the bone's internal structure or, by itself, a percentage chance of fracture.

A conference report following 533 women found that the Fragility Score distinguished women who later fractured better than the REMS T-score did. That analysis compared the two measures separately. A later prospective multicentre study evaluated categories combining both measures and found progressively higher fracture rates across the risk groups.

The Fragility Score may add information to density, but its role in choosing and monitoring treatment is less established than standard fracture-risk assessment. A concerning result belongs alongside your fracture history and other risk factors.

Spinal Changes That Affect the Comparison

Spine DXA can read artificially high when arthritis produces bone spurs or hardening, when vertebrae are compressed, or when calcium deposits in nearby blood vessels overlap the measurement. Careful interpretation can identify and exclude some affected vertebrae.

REMS software is designed to reject ultrasound signals with unexpected patterns, including some produced by calcification and structural abnormalities. Studies in people with these features have reported lower REMS readings than DXA readings. This suggests a possible advantage when DXA is distorted, but a lower result alone doesn't prove that REMS is more accurate.

Differences have also been reported in diabetes. Diabetes can increase fracture risk even when DXA density is preserved, so a reassuring density result may leave some risk unaccounted for. The available comparisons don't establish that every difference between REMS and DXA represents an error in the X-ray measurement.

Axial spondyloarthritis is an inflammatory disease that affects the spine and can produce new bone between vertebrae. One cross-sectional study found higher REMS Fragility Scores in people with this disease despite similar density scores to controls. Because the study assessed people at one point in time, it didn't establish how well the score predicts their future fractures.

REMS has also been studied in adults with osteogenesis imperfecta. This inherited condition makes bones unusually fragile. A small study found lower REMS bone-density estimates in affected adults than in healthy controls, supporting further investigation in this population.

When the Two Methods Disagree

A study in people with lupus found lower REMS density estimates at the spine and hip, but only slight-to-moderate agreement with DXA on osteoporosis classification. The difference between scans didn't establish how much bone loss was caused by lupus or steroid treatment.

An Australian hospital study of 69 adults also found poor interchangeability. Age and weight together explained most of the variation in REMS spine-density estimates within that sample. This raises questions about how much additional information the ultrasound result supplied in that setting; it doesn't establish a universal formula for every person's result.

Discordance needs interpretation of both examinations, including scan quality, the vertebrae included, and possible artifacts. Neither method should automatically be treated as correct because its score is lower.

When Results Can Be Misleading

  • Incorrect personal information: age, sex, height, and weight contribute to reference matching. Recording errors can change the estimate without a change in bone.
  • A difficult ultrasound view: abdominal tissue and bowel gas can make the vertebrae harder to assess. An inadequate acquisition may need to be repeated.
  • Operator technique: probe positioning and acquisition settings matter. Multicenter validation studies have excluded a meaningful number of spine examinations because of REMS acquisition errors.
  • Different regions or methods: results can change when different vertebrae are included. REMS and DXA values also can't be combined into a single trend.
  • A reassuring density result despite other risks: previous fragility fractures, falls, diabetes, and glucocorticoid treatment can indicate substantial risk that a density score alone doesn't capture.

Tracking Your Trend

REMS has shown good short-term repeatability under study conditions. A study with 42 spine participants reported a same-operator precision error of about 0.5%. That describes controlled rescanning, not a universal rule for deciding whether a change between annual examinations is real.

Long-term interpretation depends on the clinic's precision assessment, comparable acquisition conditions, and consistent analysis. Changes should be assessed using the underlying bone-density estimate. Percentage changes in the T-score aren't meaningful.

A series of technically comparable scans can contribute to an assessment of bone loss or treatment response. Evidence for REMS monitoring is developing, and a small change should be interpreted alongside fractures, treatment history, and other findings. Stable density can be a successful response to treatment that prevents further loss.

What Moves This Biomarker

Evidence-backed interventions that affect your REMS T-Score (Spine) level

↑ Increase
Daily abaloparatide injections
This bone-building medicine increased spine density and reduced new vertebral fractures by about 86% relative to placebo over 18 months in the ACTIVE trial. Density was measured with DXA, so the trial doesn't establish a matching change in the REMS T-score. Treatment is generally followed by a medicine that slows bone breakdown to preserve the gains.
MedicationStrong Evidence
↑ Increase
Monthly romosozumab injections for 12 months
Romosozumab increases bone formation and reduces bone breakdown, producing substantial spine-density gains and fewer vertebral fractures in randomized trials. These trials used DXA rather than REMS. It carries a cardiovascular warning, and treatment should be followed by a medicine that slows bone breakdown.
MedicationStrong Evidence
↑ Increase
Oral bisphosphonate treatment, such as alendronate or risedronate
These medicines slow bone breakdown, preserve or increase spine bone density, and reduce vertebral fractures in people with osteoporosis. The established randomized evidence measured density with DXA. A similar direction is biologically expected for REMS, but the size of a REMS change can't be inferred from DXA trial results.
MedicationModerate Evidence
↑ Increase
Denosumab injections
Denosumab suppresses bone breakdown, increases spine density, and reduces fractures. Most randomized evidence used DXA. Direct REMS evidence includes a retrospective study in women receiving aromatase inhibitors for breast cancer, in which REMS spine density rose over 18 months with denosumab. Delaying or stopping treatment without a planned follow-on medicine can cause rapid bone loss and vertebral fractures.
MedicationModerate Evidence
↓ Decrease
Long-term oral glucocorticoid treatment
Oral glucocorticoids such as prednisone can cause bone loss and increase fracture risk, with effects depending on dose, duration, and individual susceptibility. Most established evidence uses DXA. REMS comparisons in people with lupus don't isolate the drug's effect from the disease or other factors.
MedicationModerate Evidence
↑ Increase
Structured exercise for six months or longer, including progressive resistance and weight-bearing exercise
Structured exercise can preserve or modestly increase spine bone density. A review of 80 controlled studies found a small average benefit in postmenopausal women. The studies measured density with DXA, so they don't establish how much your REMS T-score will change.
ExerciseModest Evidence
↑ Increase
Exercise added to calcium and/or vitamin D supplementation
Across randomized trials, adding exercise to calcium and/or vitamin D supplementation produced a small improvement in spine density compared with supplementation alone. The measurements used DXA. This comparison supports the added exercise component; it doesn't show that supplements improve results beyond exercise in people whose intake and vitamin D status are already adequate.
ExerciseModest Evidence

Frequently Asked Questions

References

28 studies
  1. B. Cortet, E. Dennison, a. Diez-perez, M. Locquet, M. Muratore, X. Nogués, D. O. Crespo, E. Quarta, M. BrandiBone2021
  2. M. Di Paola, D. Gatti, O. Viapiana, L. Cianferotti, L. Cavalli, C. Caffarelli, F. Conversano, E. Quarta, P. Pisani, G. Girasole, a. Giusti, M. Manfredini, G. Arioli, M. Matucci-cerinic, G. Bianchi, R. Nuti, S. Gonnelli, M. Brandi, M. Muratore, M. RossiniOsteoporosis International2019
  3. G. Adami, G. Arioli, G. Bianchi, M. Brandi, C. Caffarelli, L. Cianferotti, D. Gatti, G. Girasole, S. Gonnelli, M. Manfredini, M. Muratore, E. Quarta, L. QuartaBone2020
  4. D. Ciardo, P. Pisani, F. a. Lombardi, R. Franchini, F. Conversano, S. CasciaroAnnals of the Rheumatic Diseases2021